501
Views
11
CrossRef citations to date
0
Altmetric
Author's View

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

, , &
Pages 1617-1619 | Published online: 06 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Caroline Laheurte, Jeanne Galaine, Laurent Beziaud, Magalie Dosset, Jerome Kerzerho, Claire Jacquemard, Béatrice Gaugler, Christophe Ferrand, Anne Dormoy, François Aubin, Pascale Jacoulet, Virginie Westeel, Christophe Borg, Eric Tartour, Yann Godet, Bernard Maillère & Olivier Adotévi. (2016) Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+ Th1 responses against telomerase in cancer patients. OncoImmunology 5:5.
Read now
Olivier Adotévi, Magalie Dosset, Jeanne Galaine, Laurent Beziaud, Yann Godet & Christophe Borg. (2013) Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine. Human Vaccines & Immunotherapeutics 9:5, pages 1073-1077.
Read now

Articles from other publishers (9)

Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi & Romain Loyon. (2022) Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers 14:1, pages 260.
Crossref
Magalie Dosset, Andrea Castro, Su Xian, Hannah Carter & Maurizio Zanetti. 2023. Cancer Research: An Interdisciplinary Approach. Cancer Research: An Interdisciplinary Approach 263 293 .
Ramona Clemen, Eric Freund, Daniel Mrochen, Lea Miebach, Anke Schmidt, Bernhard H. Rauch, Jan‐Wilm Lackmann, Ulrike Martens, Kristian Wende, Michael Lalk, Mihaela Delcea, Barbara M. Bröker & Sander Bekeschus. (2021) Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT‐II T Cell Activation Conferring Tumor Protection in Mice. Advanced Science 8:10, pages 2003395.
Crossref
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas & Lionel Apetoh. (2020) Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors. Cells 9:7, pages 1727.
Crossref
Magalie Dosset, Andrea Castro, Hannah Carter & Maurizio Zanetti. (2020) Telomerase and CD4 T Cell Immunity in Cancer. Cancers 12:6, pages 1687.
Crossref
Maurizio Zanetti. (2016) A second chance for telomerase reverse transcriptase in anticancer immunotherapy. Nature Reviews Clinical Oncology 14:2, pages 115-128.
Crossref
Anne-Pauline Bellanger, Thibaud Lignon, Yann Godet, Bénédicte Rognon, Gabriel Reboux, Houssein Gbaguidi-Haore, Christophe Borg & Laurence Millon. (2017) Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune response. Journal of Immunological Methods 440, pages 67-73.
Crossref
Jeanne Galaine, Guillaume Kellermann, Yves Guillaume, Romain Boidot, Emilie Picard, Romain Loyon, Lise Queiroz, Laura Boullerot, Laurent Beziaud, Marine Jary, Laura Mansi, Claire André, Lydie Lethier, Evelyne Ségal-Bendirdjian, Christophe Borg, Yann Godet & Olivier Adotévi. (2016) Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells. The Journal of Immunology 197:5, pages 1597-1608.
Crossref
Furong Kou, Zhihao Lu, Jian Li, Xiaotian Zhang, Ming Lu, Jun Zhou, Xicheng Wang, Jifang Gong, Jing Gao, Jie Li, Yan Li & Lin Shen. (2016) Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first‐line chemotherapy. Cancer Medicine 5:5, pages 778-786.
Crossref